Abstract: The United States is still the most severely affected country in the world. The cumulative number of cases has exceeded 6.51 million. With the arrival of autumn, the second wave of epidemics may appear within a few weeks.
September 9th The United States is still the most severely affected country in the world. The cumulative number of cases has exceeded 6.51 million. With the arrival of autumn, the second wave of epidemics may appear within a few weeks. While the market was eagerly looking forward to the vaccine, AstraZeneca suspended the Phase III clinical trial of the new crown vaccine due to a serious adverse reaction in one patient.
On Wednesday (September 9), silver futures opened at US$26.905 per ounce, the highest reached US$26.920 per ounce, and the lowest touched US$26.660 per ounce. As of press time, it temporarily reported US$26.815 per ounce, a 0.65% decline.
A second wave of outbreaks in the U.S. in a few weeks
Worldometers world real-time statistics show that as of 8:16 on September 9th, Beijing time, the cumulative number of confirmed cases of new coronary pneumonia worldwide has exceeded 27.71 million, reaching 27719529, and the cumulative number of deaths has exceeded 900,000, reaching 900,804. The cumulative number of confirmed cases of new coronary pneumonia in the United States is the largest in the world, exceeding 6.51 million, with a cumulative total of 194,000 deaths.
American infectious disease experts warned that the number of new coronary pneumonia cases in the United States may surge again in cold weather, and the "second wave" of epidemics that people are worried about may appear in the United States in a few weeks.
According to the health news website Stat News, AstraZeneca suspended the Phase III clinical trial of the new crown vaccine because a British participant suspected a serious adverse reaction, and risk sentiment in the global market was once again hit.
An AstraZeneca spokesperson said in a statement that the company's standard review procedures have resulted in a suspension of vaccination to allow for review of safety data. AstraZeneca said that it is voluntarily suspending the trial of the new crown vaccine so that the independent committee can review safety data. According to a person familiar with the matter, the nature of the adverse reaction and when it occurred is still unclear, but the participant is expected to recover.
The spokesperson said that the suspension of the experiment is a routine action. During the investigation, once there is a disease that may not be explained in an experiment, this action must be taken to ensure that we maintain the integrity of the experiment. The spokesperson also said that the company is speeding up the review of this single incident to minimize the potential impact on the time of the experiment.
Silver futures market outlook
The analysis pointed out that despite the high risk aversion in the market, the US dollar has become the darling of the market, and the rise of the US dollar is the main burden on the price of precious metals.
In the short term, US$26.7 is the key support for silver futures. The Kshitij consulting service team said yesterday that as long as it stays above $26.70 per ounce, there is still room for silver futures to rebound. If you can't hold $26.70/ounce, this may drag the price of silver to $24/ounce. For now, we will wait to confirm whether silver futures fell below $26.70 per ounce or rebounded from this level.
At present, silver futures are temporarily trading near US$26.8. Judging from the 1-hour chart, the red kinetic energy column continues weakly, and the bulls rebound encounter strong resistance.